The thyroid is a butterfly-shaped gland located at the front of your throat. It serves several essential functions, including producing hormones that control body temperature, weight, energy level, heart rate and more.
Cancer occurs when abnormal cells in the thyroid begin to grow and multiply uncontrollably.
There are four types of thyroid cancer: papillary (most common), follicular, medullary, and anaplastic (rare and aggressive).
Thyroid cancer is highly treatable, especially when caught early. Most early diagnoses occur when patients notice swelling, nodules or lumps on their necks.
Your thyroid cancer care team will work with you to implement a personalized treatment plan based on your specific diagnosis. There are several options for treating thyroid cancer.
City of Hope is a recognized leader in thyroid cancer research. We offer access to numerous clinical trials and new therapies that are not readily available elsewhere.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your loved ones take each step during and after thyroid cancer treatment.
City of Hope is a nationally recognized leader in the research and treatment of thyroid cancer. U.S. News & World Report has named City of Hope a best hospital for cancer for over a decade.
Our multidisciplinary staff uses an integrated approach to treating thyroid cancer by combining the latest research findings with outstanding patient care.
Our Program Highlights:
- Comprehensive diagnostic tools
- Innovative, minimally invasive surgical approaches that reduce side effects and recovery time
- Highly precise radiation delivery, including radioactive iodine therapy
- Individually customized chemotherapy, targeted therapy and immune therapy regimens
- Expert endocrinology care from our diabetes, endocrinology and metabolism team
- Clinical trials that offer promising new approaches to detect and treat thyroid cancer
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Arya Amini, M.D., is a radiation oncologist and associate professor in the Department of Radiation Oncology at City of Hope.
Sasan Fazeli, M.D., is an endocrinologist in the Department of Diabetes, Endocrinology & Metabolism. Dr. Fazeli specializes in endocrinology with a special interest in the genetic profile of thyroid cancers, the latest adrenal and neuroendocrine tumor treatments, and advancements in the field of
Wei Feng, M.D., is a board certified endocrinologist with expertise in many areas such as diabetes, thyroid, pituitary, osteoporosis, PCOS, obesity, lipid disorder, and adrenal disease.
Thomas J. Gernon, M.D., is an otolaryngologist specializing in the treatment of head and neck cancers, particularly HPV-related malignancies, at City of Hope in Duarte and South Pasadena.
Fouad R Kandeel, M.D., Ph.D., is the director of the Islet Cell Transplantation Program and Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research at City of Hope.
Ellie Maghami, M.D., is a head, neck and thryoid cancer surgeon and The Norman and Sadie Lee Foundation Endowed Professor in Head and Neck Cancer.
Dr. Pooja Manroa specializes in endocrinology and uses a systematic and methodical approach to diagnosing and treating endocrine disorders.
Erminia Massarelli, M.D., Ph.D., M.S., is the co-director of the Lung Cancer and Thoracic Oncology Program, and an associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope. She specializes in lung and head and neck cancers.
Behrouz Salehian-Dardashti, M.D. is an endocrinologist specializing in treating thyroid disorders, pituitary disorders and neuroendocrine tumors. He is also director of the diabetes cardiovascular risk reduction program at City of Hope.
Raynald Samoa, M.D.., is an Assistant Professor, Department of Diabetes, Endocrinology & Metabolism, as well as an Endocrinologist, at City of Hope in Los Angeles, CA.
Sagus Sampath, M.D., Radiation Oncologist | City of Hope, Los Angeles, CA
Karen Tsai, M.D., is an assistant Clinical Professor in the Department of Diabetes, Endocrinology & Metabolism, specializing in treating thyroid diseases. She is especially interested in thyroid cancers, bone and calcium disorders related to malignancies and diabetes, and helping patients who
Yan Xing, M.D., Ph.D., is a medical oncologist and an assistant professor in the Department of Medical Oncology & Therapeutics Research.